Sort
35,931 grants matching “parkinsons”
Chemical synthesis of G protein-coupled receptors using sequential DNA-templated reactions
$2,230,906Nicholas Stephanopoulos · Arizona State University-Tempe Campus · DP2 · FY2018 · GM
Stem Cell Biology And Brain Disease
$2,230,852Ronald D McKay · National Institute Of Neurological Disorders And Stroke · Z01 · FY2008 · NS
COBRE GRANT
$2,230,641Jeffrey L. Cummings · Cleveland Clinic Foundation · P20 · FY2017 · GM
Effects-Related Biomarkers of Environmental Neurotoxic Exposures
$2,229,662Thomas M Burbacher · University Of Washington · P42 · FY2021 · ES
Proteopathies of the Aging Central Nervous System
$2,224,187J. David Gladstone Institutes · P01 · FY2003 · AG
Multiscale chemical approaches to map oxidative stress
$2,222,098Brent Randall Martin · University Of Michigan At Ann Arbor · DP2 · FY2014 · GM
Mechanisms of dopamine neuron degeneration
$2,212,850Robert E Burke · Columbia University Health Sciences · P50 · FY2012 · NS
Parkinson's Disease Research Center of Excellence
$2,210,330Johns Hopkins University · P50 · FY2005 · NS
In Vivo Control and Functional Visualization of Stem Cell-Driven CNS Regeneration
$2,209,908Jin Hyung Lee · Stanford University · DP2 · FY2010 · OD
Genome wide SNP analysis in Parkinson's disease
$2,208,630Andrew Singleton · National Institute On Aging · ZIA · FY2019 · AG
Functional and Pharmacological Significance of Receptor Heteromers in the CNS
$2,206,889Sergi Ferre · National Institute On Drug Abuse · ZIA · FY2017 · DA
Effects of Coenzyme Q10 in Parkinson Disease-Phase 3
$2,206,627Weill Medical College Of Cornell Univ · U01 · FY2005 · NS
Functional and Pharmacological Significance of Receptor Heteromers in the CNS
$2,203,646Sergi Ferre · National Institute On Drug Abuse · ZIA · FY2018 · DA
Identification and Verification of S-Nitrosylated Proteins in Bodily Fluids as Biomarkers for Parkinson's Disease and Lewy Body Dementia
$2,199,931Tomohiro Nakamura · Scripps Research Institute, The · R61 · FY2021 · NS
Circuit-based deep brain stimulation for Parkinson's disease
$2,198,985Jerrold L Vitek · University Of Minnesota · P50 · FY2024 · NS
Effects-Related Biomarkers of Environmental Neurotoxic Exposures
$2,195,825Evan P Gallagher · University Of Washington · P42 · FY2013 · ES
Role of mitochondria in neurodegenerative diseases
$2,194,533Richard Youle · National Institute Of Neurological Disorders And Stroke · ZIA · FY2021 · NS
Mitochondrial transport and energy metabolism in synaptic transmission and nerve degeneration and regeneration
$2,193,277Zu-Hang Sheng · National Institute Of Neurological Disorders And Stroke · ZIA · FY2019 · NS
How Serine-129 Phosphorylation Status Affects the Spreading of α-Synuclein Pathology in Vivo: a Study in Knock-in Animals
$2,192,716Ulf Dettmer · Brigham And Women'S Hospital · RF1 · FY2023 · NS
Functional Microbiomics, Inflammation and Pathogenicity
$2,191,620Richard J Lamont · University Of Louisville · P20 · FY2019 · GM
Translational Science Engaging North Dakota (TRANSCEND)
$2,187,647Gary G Schwartz · University Of North Dakota · P20 · FY2024 · GM
Mouse BIRN
$2,182,931University Of California Los Angeles · U24 · FY2005 · RR
Molecular signaling during development and maturation of the nervous system
$2,179,383David Talmage · National Institute Of Neurological Disorders And Stroke · ZIA · FY2022 · NS
Functional Microbiomics, Inflammation and Pathogenicity
$2,174,084Richard J Lamont · University Of Louisville · P20 · FY2020 · GM
MGH/MIT MORRIS UDALL CENTER OF EXCELLENCE IN PD RESEARCH
$2,173,196Anne B Young · Massachusetts General Hospital · P50 · FY2008 · NS